Pancreatic Cancer Research

ResearcherUniversity of MissouriActive in the last 2 years

Yujiang Fang

Matched on ORCID iD 0000-0002-9107-7374; OpenAlex author ID A5068594044, A5075245734. Sources: OpenAlex.

Their work

Papers
8 (first author 0, last author 7)
Trials
0
Grants
0
Labs led
1
Collaborators
10
Papers, trials and grants by year

2017: 1 paper · 2018: 1 paper · 2019: 2 papers · 2020: none · 2021: none · 2022: 1 paper · 2023: 1 paper · 2024: 1 paper · 2025: none · 2026: 1 paper

Papers 8

  1. Combination Immunotherapy in Pancreatic Cancer: Current Clinical Evidence and Mechanistic Rationale for Overcoming a "Cold" Tumor. Last author DOI 10.3390/cancers18183019↗
  2. Exploring the role of antigen-presenting cancer-associated fibroblasts and CD74 on the pancreatic ductal adenocarcinoma tumor microenvironment. Last author DOI 10.1007/s12032-024-02564-6↗
  3. The Novel Use of IL-28 as an Effective Radiosensitizer in Pancreatic Cancer. Last author DOI 10.21873/anticanres.16347↗
  4. The Effect of Asparagus Extract on Pancreatic Cancer: An Intriguing Surprise. Last author DOI 10.21873/anticanres.15721↗
  5. Correction to: IL-39 acts as a friend to pancreatic cancer. Last author DOI 10.1007/s12032-018-1244-y↗
  6. IL-29 Exhibits Anti-Tumor Effect on Pan-48 Pancreatic Cancer Cells by Up-regulation of P21 and Bax. Last author DOI 10.21873/anticanres.13495↗
  7. IL-39 acts as a friend to pancreatic cancer. Last author DOI 10.1007/s12032-018-1236-y↗
  8. IL-33 acts as a foe to MIA PaCa-2 pancreatic cancer. Co-author DOI 10.1007/s12032-016-0880-3↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Bode T. Eisenmenger · 1 shared paper, 2026 · strength 0.33
  2. Huaping Xiao · 2 shared papers, 2022–2023 · strength 0.31
  3. Michael B. Nicholl · 2 shared papers, 2017–2023 · strength 0.23
  4. Michael E. Thomas · 1 shared paper, 2024 · strength 0.23
  5. Xuhui Chen · 1 shared paper, 2023 · strength 0.17
  6. Alicia A. Manning · 2 shared papers, 2018–2019 · strength 0.17
  7. Zuliang Deng · 1 shared paper, 2022 · strength 0.14
  8. Lei Zhao · 2 shared papers, 2017–2018 · strength 0.14
  9. Dean Balabanov · 1 shared paper, 2019 · strength 0.10
  10. Lei Zhao · 1 shared paper, 2019 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.